Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hasan Rajabi

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Cancer Research|July 23, 2013
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cellsDina Stroopinsky, Jacalyn Rosenblatt, Keisuke Ito, et al.
Journal of Cellular and Molecular Medicine|May 16, 2018
MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanismDina Stroopinsky, Hasan Rajabi, Myrna Nahas, et al.
British Journal of Haematology|January 21, 2017
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1Michal Bar-Natan, Dina Stroopinsky, Katarina Luptakova, et al.
Nature Communications|February 26, 2020
Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancerYota Yasumizu, Hasan Rajabi, Caining Jin, et al.
Nature Communications|January 19, 2020
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancerYota Yasumizu, Hasan Rajabi, Caining Jin, et al.
Blood|January 28, 2017
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemiaAthalia Rachel Pyzer, Dina Stroopinsky, Hasan Rajabi, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Cancer Research|July 23, 2013
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cellsDina Stroopinsky, Jacalyn Rosenblatt, Keisuke Ito, et al.
Journal of Cellular and Molecular Medicine|May 16, 2018
MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanismDina Stroopinsky, Hasan Rajabi, Myrna Nahas, et al.
British Journal of Haematology|January 21, 2017
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1Michal Bar-Natan, Dina Stroopinsky, Katarina Luptakova, et al.
Nature Communications|February 26, 2020
Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancerYota Yasumizu, Hasan Rajabi, Caining Jin, et al.
Nature Communications|January 19, 2020
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancerYota Yasumizu, Hasan Rajabi, Caining Jin, et al.
Blood|January 28, 2017
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemiaAthalia Rachel Pyzer, Dina Stroopinsky, Hasan Rajabi, et al.
Pageof 6